Global Cardiac POC Testing Devices Market
Global Cardiac POC Testing Devices Market 2014-2018
Cardiac POC tests are medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include troponin and BNP tests that are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes, and heart failure. These tests help to detect the enzymes released during heart failure and in other critical cardiac conditions that release creatine kinase, troponin, LDH isoenzymes, and BNP. These tests also help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in diagnosis and treatment.
Covered in this Report
This report covers the present scenario and growth prospects of the Global Cardiac POC Testing Devices market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of two types of cardiac POC testing devices: troponin and BNP testing devices. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC Testing Devices market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Abbott Laboratories
Alere Inc.
Roche Diagnostics
Other Prominent Vendors
Beckman Coulter
BG Medicine
Boston Scientific
Medtronic
Randox Laboratories
Response Biomedical
Key Market Driver
Increasing Incidence of Cardiac Disorders
For a full, detailed list, view our report.
Key Market Challenge
Lack of Specific Measures to Detect the Presence of CVDs
For a full, detailed list, view our report.
Key Market Trend
Introduction of Enhanced Products
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
Cardiac POC tests are medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include troponin and BNP tests that are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes, and heart failure. These tests help to detect the enzymes released during heart failure and in other critical cardiac conditions that release creatine kinase, troponin, LDH isoenzymes, and BNP. These tests also help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in diagnosis and treatment.
Covered in this Report
This report covers the present scenario and growth prospects of the Global Cardiac POC Testing Devices market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of two types of cardiac POC testing devices: troponin and BNP testing devices. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC Testing Devices market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Abbott Laboratories
Alere Inc.
Roche Diagnostics
Other Prominent Vendors
Beckman Coulter
BG Medicine
Boston Scientific
Medtronic
Randox Laboratories
Response Biomedical
Key Market Driver
Increasing Incidence of Cardiac Disorders
For a full, detailed list, view our report.
Key Market Challenge
Lack of Specific Measures to Detect the Presence of CVDs
For a full, detailed list, view our report.
Key Market Trend
Introduction of Enhanced Products
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?